CA2044132A1 - Transdermal Acrylic Multipolymer Drug Delivery System - Google Patents

Transdermal Acrylic Multipolymer Drug Delivery System

Info

Publication number
CA2044132A1
CA2044132A1 CA2044132A CA2044132A CA2044132A1 CA 2044132 A1 CA2044132 A1 CA 2044132A1 CA 2044132 A CA2044132 A CA 2044132A CA 2044132 A CA2044132 A CA 2044132A CA 2044132 A1 CA2044132 A1 CA 2044132A1
Authority
CA
Canada
Prior art keywords
multipolymer
drug
delivery system
drug delivery
crosslinking agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2044132A
Other languages
French (fr)
Other versions
CA2044132C (en
Inventor
Steven Sablotsky
Joseph A. Gentile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noven Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2044132A1 publication Critical patent/CA2044132A1/en
Application granted granted Critical
Publication of CA2044132C publication Critical patent/CA2044132C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B07—SEPARATING SOLIDS FROM SOLIDS; SORTING
    • B07C—POSTAL SORTING; SORTING INDIVIDUAL ARTICLES, OR BULK MATERIAL FIT TO BE SORTED PIECE-MEAL, e.g. BY PICKING
    • B07C5/00—Sorting according to a characteristic or feature of the articles or material being sorted, e.g. by control effected by devices which detect or measure such characteristic or feature; Sorting by manually actuated devices, e.g. switches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A61L15/585—Mixtures of macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B26—HAND CUTTING TOOLS; CUTTING; SEVERING
    • B26F—PERFORATING; PUNCHING; CUTTING-OUT; STAMPING-OUT; SEVERING BY MEANS OTHER THAN CUTTING
    • B26F1/00—Perforating; Punching; Cutting-out; Stamping-out; Apparatus therefor
    • B26F1/38—Cutting-out; Stamping-out
    • B26F1/44—Cutters therefor; Dies therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B26—HAND CUTTING TOOLS; CUTTING; SEVERING
    • B26F—PERFORATING; PUNCHING; CUTTING-OUT; STAMPING-OUT; SEVERING BY MEANS OTHER THAN CUTTING
    • B26F1/00—Perforating; Punching; Cutting-out; Stamping-out; Apparatus therefor
    • B26F1/38—Cutting-out; Stamping-out
    • B26F1/384—Cutting-out; Stamping-out using rotating drums

Abstract

A dermal composition comprising a drug, a multipolymer of ethylene-vinyl acetate, a acrylic polymer, and optionally one or more mo???mers, a natural or synthetic rubber and a tackifying agent.
The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably, 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a crosslinking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multipolymer, drug and optional crosslinking agent and additional ingredients in solution or suspension or emulsion followed by removal of excess solvent.
CA002044132A 1989-01-11 1990-01-10 Transdermal acrylic multipolymer drug delivery system Expired - Lifetime CA2044132C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/295,847 US4994267A (en) 1988-03-04 1989-01-11 Transdermal acrylic multipolymer drug delivery system
US295,847 1989-01-11

Publications (2)

Publication Number Publication Date
CA2044132A1 true CA2044132A1 (en) 1990-07-12
CA2044132C CA2044132C (en) 1997-05-06

Family

ID=23139462

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002044132A Expired - Lifetime CA2044132C (en) 1989-01-11 1990-01-10 Transdermal acrylic multipolymer drug delivery system

Country Status (14)

Country Link
US (1) US4994267A (en)
EP (3) EP0634179A1 (en)
JP (1) JPH0793939B2 (en)
KR (1) KR920703220A (en)
AT (1) ATE122240T1 (en)
CA (1) CA2044132C (en)
DE (1) DE69019175T2 (en)
DK (1) DK0379045T3 (en)
ES (1) ES2071683T3 (en)
HK (1) HK1006155A1 (en)
IE (1) IE69048B1 (en)
NL (1) NL9020159A (en)
PT (1) PT92830B (en)
WO (1) WO1990007940A1 (en)

Families Citing this family (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) † 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
AR246186A1 (en) † 1989-11-17 1994-07-29 Beta Pharm Co Procedure for manufacturing a device for administering stradiol through the skin.
JP3273430B2 (en) * 1989-12-28 2002-04-08 日東電工株式会社 Estrogen-containing gel preparation
ES2097145T3 (en) 1990-03-28 1997-04-01 Noven Pharma METHOD AND DEVICE FOR THE RELEASE OF DRUGS IN THE SKIN.
ATE120368T1 (en) * 1990-05-17 1995-04-15 Hisamitsu Pharmaceutical Co TRANSDERMAL PREPARATION CONTAINING ESTRADIOL.
DE4020144A1 (en) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Patches for topical or transdermal drug delivery - with adhesive layer contg. polyacrylate adhesive and film former
DE4110027C2 (en) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Process for packaging transdermal therapeutic patches
DE59203307D1 (en) * 1991-06-10 1995-09-21 Lohmann Therapie Syst Lts NITROGLYCERIN PLASTER AND METHOD FOR THE PRODUCTION THEREOF.
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5352456A (en) * 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
IT1253265B (en) * 1991-11-25 1995-07-14 Rotta Research Lab ACRYLIC-BASED ADHESIVE COPOLYMER MATRIX PREPARATION FOR THE TRANSDERMAL EXTRADIOL RELEASE.
JP2960832B2 (en) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト Estradiol administration system
JP3624315B2 (en) * 1992-07-29 2005-03-02 バクスター、インターナショナル、インコーポレイテッド Biological material with hydrophilic surface
DE4230588C1 (en) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-containing plaster for the transdermal application of steroid hormones and process for its production
DE4237453C1 (en) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
FR2699406B1 (en) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films based on copolymers, their applications in transdermal systems and their preparation processes.
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
JP2539330B2 (en) * 1993-05-11 1996-10-02 日東電工株式会社 Medical adhesive and medical external material formed using the same
WO1995001767A1 (en) * 1993-07-08 1995-01-19 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
FR2717688B1 (en) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Transdermal matrix system for administration of an estrogen and / or an EVA-based progestin.
FR2717689B1 (en) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Transdermal matrix system for the administration of an estrogen and / or a progestin based on a styrene-isoprene-styrene copolymer.
ATE194281T1 (en) 1994-09-14 2000-07-15 Minnesota Mining & Mfg TRANSDERMAL ACTIVE RELEASE MATRIX
EP0799285A1 (en) * 1994-12-20 1997-10-08 Minnesota Mining And Manufacturing Company Retroreflective sheeting articles
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
AU4657896A (en) * 1995-01-19 1996-08-07 Cygnus, Inc. Polyisobutylene adhesives containing high TG tackifier for transdermal devices
US6630238B2 (en) 1995-02-16 2003-10-07 3M Innovative Properties Company Blended pressure-sensitive adhesives
US6632522B1 (en) 1995-02-16 2003-10-14 3M Innovative Properties Company Blended pressure-sensitive adhesives
US6063838A (en) * 1995-02-16 2000-05-16 3M Innovative Properties Company Blended pressure-sensitive adhesives
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
EP0833671A2 (en) * 1995-06-07 1998-04-08 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
AU703593B2 (en) * 1995-06-07 1999-03-25 Ortho-Mcneil Pharmaceutical, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5795834A (en) * 1995-12-22 1998-08-18 Minnesota Mining & Manufacturing Company Adhesive tape and method of making
DE19628999C1 (en) * 1996-07-18 1998-03-12 Lohmann Gmbh & Co Kg Medical pressure sensitive adhesives with high water vapor permeability and adhesive strength and plasters provided with them and their use
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
WO1998030210A1 (en) 1997-01-07 1998-07-16 Teijin Limited Patch containing isosorbide dinitrate
DE19700913C2 (en) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of hormones
IT1290255B1 (en) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L SHAPED SUPPORT ADHERING TO THE SKIN FOR THE SALE OF COSMETIC OR PHARMACOLOGICAL SUBSTANCES AND METHOD FOR ITS MANUFACTURE
DE19706824C1 (en) * 1997-02-21 1998-03-26 Lohmann Therapie Syst Lts Plaster for transdermal drug delivery
JP4136029B2 (en) * 1997-05-12 2008-08-20 帝國製薬株式会社 Patch containing isosorbide nitrate
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US20050260246A1 (en) * 1998-04-27 2005-11-24 Chudzik Stephen J Bioactive agent release coating
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE19830648A1 (en) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Composition containing glycerol trinitrate, process for its preparation and its use
US6532386B2 (en) 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
US6129929A (en) * 1998-10-30 2000-10-10 Noven Pharmaceuticals, Inc. Patch applicator
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
JP2002534370A (en) 1998-12-30 2002-10-15 デクセル リミテッド Dispersible concentrate for delivering cyclosporin
WO2000041538A2 (en) * 1999-01-14 2000-07-20 Noven Pharmaceuticals, Inc. Dermal compositions
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US6337086B1 (en) 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
ATE290902T1 (en) 1999-04-16 2005-04-15 Johnson & Johnson Consumer DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICATION WITH INTERNAL SENSORS
US7063859B1 (en) * 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6465004B1 (en) 1999-06-05 2002-10-15 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
GB9918291D0 (en) * 1999-08-03 1999-10-06 Croda Int Plc Cold sealable adhesive
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20020004065A1 (en) 2000-01-20 2002-01-10 David Kanios Compositions and methods to effect the release profile in the transdermal administration of active agents
US6905016B2 (en) 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
US6743880B2 (en) 2000-03-31 2004-06-01 Avery Denison Corporation Hydrophilic polymers and methods of preparation
US6653427B2 (en) 2000-03-31 2003-11-25 Avery Dennison Corporation Hydrophilic polymers, pressure sensitive adhesives and coatings
US6706836B1 (en) * 2000-03-31 2004-03-16 Avery Dennison Corporation Hydrophilic polymers, pressure sensitive adhesives and coatings
DE10032537A1 (en) * 2000-07-05 2002-01-31 Labtec Gmbh Dermal system containing 2- (3-benzophenyl) propionic acid
KR100940245B1 (en) * 2000-09-19 2010-02-04 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 Non-reactive adhesive useful in transdermal drug delivery systems
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10060550C1 (en) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermal therapeutic system for administration of oxybutynin, especially for treatment of bladder dysfunction, having two-phase matrix layer of active agent-containing droplets dispersed in adhesive
KR100846642B1 (en) * 2001-03-07 2008-07-16 히사미쓰 세이야꾸 가부시키가이샤 Patch agent
RU2708563C2 (en) * 2001-03-16 2019-12-10 Алза Корпорейшн Transdermal patch for administering fentanyl
DE10118282A1 (en) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Pressure sensitive adhesive based on ethylene-vinyl acetate copolymers and adhesive resins, for medical purposes
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
JP4116447B2 (en) 2001-05-01 2008-07-09 エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス Hydrogel composition
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
CA2448689C (en) * 2001-05-31 2009-09-01 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patches
CA2457314A1 (en) * 2001-08-10 2003-02-20 Hisamitsu Pharmaceutical Co., Inc. Percutaneous absorption preparations
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
US20030175333A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
JP4354678B2 (en) * 2002-08-28 2009-10-28 久光製薬株式会社 Patch
US20140107555A1 (en) * 2002-10-23 2014-04-17 Covidien Lp Antimicrobial multilayer wound dressing
DE10304988A1 (en) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with improved skin adhesion
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
EP2316440A1 (en) * 2003-04-30 2011-05-04 Purdue Pharma L.P. Transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer and one fluid communication between the surface of the active agent and the adverse agent
WO2005025549A2 (en) * 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
JP2007509951A (en) * 2003-10-28 2007-04-19 ノーヴェン ファーマシューティカルズ インコーポレイテッド Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
US8658201B2 (en) 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
ES2526700T3 (en) * 2004-08-05 2015-01-14 Corium International, Inc. Adhesive composition
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
US20060078604A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
KR100810947B1 (en) 2005-01-28 2008-03-10 롬 앤드 하아스 컴패니 Medical films and articles prepared from emulsion polymers
WO2007011972A2 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
DE502006002907D1 (en) * 2005-09-13 2009-04-02 Sabine Hohmann COMPOSITE MATERIAL WITH ACTIVE SUBSTANCES
DE102005056393A1 (en) * 2005-11-24 2007-05-31 Grünenthal GmbH Pressure-sensitive adhesive, useful particularly for plasters and transdermal drug-delivery systems, contains specific multicyclic hydrocarbon substituted by polar groups
JP2009528357A (en) * 2006-02-27 2009-08-06 ノーヴェン ファーマシューティカルズ インコーポレイテッド Compositions and methods for administration of aminofunctional agents
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US20070287727A1 (en) * 2006-06-08 2007-12-13 Jacob Hiller Anti-Nicotine Treatment
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) * 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
CA2667477C (en) * 2006-10-27 2015-12-08 Noven Pharmaceuticals, Inc. Transdermal delivery of ketoprofen polar derivatives
EP2187969A2 (en) * 2007-08-17 2010-05-26 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
CN101902996B (en) * 2007-10-15 2014-11-26 阿尔扎公司 Once-a-day replacement transdermal administration of fentanyl
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
DE102008037845A1 (en) * 2008-08-15 2010-02-18 Tesa Se PSA
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
US8784879B2 (en) 2009-01-14 2014-07-22 Corium International, Inc. Transdermal administration of tamsulosin
WO2011068722A1 (en) 2009-12-01 2011-06-09 Noven Pharmaceuticals, Inc. Transdermal testosterone device and delivery
DE102011100619A1 (en) 2010-05-05 2012-01-05 Amw Gmbh Therapeutic system, useful to treat chronic pain, comprises active agent impermeable carrier, active agent reservoir containing e.g. opioid receptor agonist, optionally active agent-permeable membrane and active agent impermeable layer
WO2012092165A1 (en) 2010-12-29 2012-07-05 Noven Pharmaceuticals, Inc. Transdermal drug delivery system comprising levonorgestrel acetate
DE102011114411A1 (en) * 2011-09-26 2013-03-28 Lts Lohmann Therapie-Systeme Ag Plaster with adjustable occlusion
TW201431570A (en) 2012-11-22 2014-08-16 Ucb Pharma Gmbh Multi-day patch for the transdermal administration of rotigotine
WO2014105783A1 (en) 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine and clonidine
US20140220336A1 (en) * 2013-02-05 2014-08-07 Honeywell International Inc. Pressure-sensitive adhesives that minimize plasticizer migration, pressure-sensitive adhesive articles with such pressure-sensitive adhesives, and methods for fabricating such pressure-sensitive adhesives
AR095259A1 (en) 2013-03-15 2015-09-30 Noven Pharma COMPOSITIONS AND METHODS FOR THE TRANSDERMAL ADMINISTRATION OF TERTIARY AMINE DRUGS
EP3016641B1 (en) 2013-07-03 2018-09-05 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system having an electronic component
CA2924231C (en) 2013-10-07 2018-04-03 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
WO2015054059A2 (en) 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
TWI629067B (en) * 2013-10-07 2018-07-11 美商帝國製藥美國股份有限公司 Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
US10307380B1 (en) 2014-03-04 2019-06-04 Prosolus, Inc. Composition and method for transdermal lidocaine delivery
JP6573913B2 (en) 2014-05-20 2019-09-11 エルテーエス ローマン テラピー−ジステーメ アーゲー Transdermal delivery system containing rotigotine
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
EP3145504B1 (en) 2014-05-20 2023-07-26 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an interface mediator
FR3021973B1 (en) * 2014-06-05 2016-07-01 Bostik Sa PEELABLE GLUE COMPOSITION
US10406116B2 (en) 2015-02-06 2019-09-10 Noven Pharmaceuticals, Inc. Pressure-sensitive adhesives for transdermal drug delivery
ES2748352T3 (en) 2015-02-06 2020-03-16 Noven Pharma Pressure sensitive adhesives for transdermal drug delivery
KR20170125939A (en) 2015-03-04 2017-11-15 노벤 파머수티컬즈, 인코퍼레이티드 Oligomer / polymer silicone fluids for use in transdermal drug delivery systems
JP7257739B2 (en) 2015-07-02 2023-04-14 ノーヴェン ファーマシューティカルズ インコーポレイテッド Transdermal drug delivery system for levonorgestrel and ethinyl estradiol
JP2018537451A (en) 2015-11-16 2018-12-20 ノーヴェン ファーマシューティカルズ インコーポレイテッド Stretchable backing layer for transdermal drug delivery system
US11472950B2 (en) * 2016-12-21 2022-10-18 Braskem S.A. Modified ethylene vinyl acetate compositions, polymer blends and films made therefrom

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS57181020A (en) * 1981-04-30 1982-11-08 Kao Corp Poultice base composition
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
DE3682165D1 (en) * 1985-11-08 1991-11-28 Nitto Denko Corp USE OF ADHESIVE PLASTERS FOR THE SKIN AND PERCUTANEOUS PREPARATIONS.
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
JPH02503672A (en) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー Fatty acids and their short chain esters as penetration enhancers in aqueous systems
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
CA2004203A1 (en) * 1988-12-01 1990-06-01 Sharad K. Govil Compositions for transdermal delivery of estradiol

Also Published As

Publication number Publication date
EP0379045A1 (en) 1990-07-25
US4994267A (en) 1991-02-19
WO1990007940A1 (en) 1990-07-26
PT92830A (en) 1990-07-31
AU5034990A (en) 1990-08-13
IE69048B1 (en) 1996-08-07
AU632534B2 (en) 1993-01-07
EP0453505A1 (en) 1991-10-30
JPH0793939B2 (en) 1995-10-11
HK1006155A1 (en) 1999-02-12
NL9020159A (en) 1991-01-02
EP0634179A1 (en) 1995-01-18
ATE122240T1 (en) 1995-05-15
DE69019175T2 (en) 1996-01-18
PT92830B (en) 1995-12-29
DK0379045T3 (en) 1995-10-09
IE900090L (en) 1990-07-11
ES2071683T3 (en) 1995-07-01
EP0379045B1 (en) 1995-05-10
JPH04502719A (en) 1992-05-21
KR920703220A (en) 1992-12-17
CA2044132C (en) 1997-05-06
DE69019175D1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
CA2044132A1 (en) Transdermal Acrylic Multipolymer Drug Delivery System
HK1006285A1 (en) Transdermal multipolymer drug delivery system
EP0280413B1 (en) Skin permeation enhancer compositions using sucrose esters
US4940586A (en) Skin permeation enhancer compositions using sucrose esters
US4900555A (en) Skin permeation enhancer compositions using sucrose esters
US4746515A (en) Skin permeation enhancer compositions using glycerol monolaurate
EP0607434B1 (en) Anti-inflammatory analgesic plaster
US5641504A (en) Skin permeation enhancer compositions using glycerol monolinoleate
US6007835A (en) Transdermal matrix system
AU7396294A (en) Incorporating poly-n-vinyl amide in a transdermal system
CA2065311A1 (en) Solid Matrix System for Transdermal Drug Delivery
IE894079L (en) Transdermal therapeutical system comprising physostigmine as¹active component and process for the production thereof
CA2056653A1 (en) Preparation for transdermal drug administration
RU94035739A (en) Pharmaceutical composition containing nifedipin and method of its preparing
JP2572763B2 (en) Etofenamat-containing patch
AU695698B2 (en) Scopolamine patch
JP3523275B2 (en) Patch
JP3218473B2 (en) Keratin softening plaster
KR950703948A (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING PHYSOSTIGMIN THROUGH THE SKIN <AND A METHOD OF PRODUCING THE SYSTEM
CA1175746A (en) Medicinal adhesive sheets for heart diseases and a process for the preparation thereof
JPH10316825A (en) Adhesive composition
JPH01299217A (en) Plaster for external use
IE921615A1 (en) Skin permeation enhancer compositions using glycerol¹monolinoleate

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry
MKEX Expiry

Effective date: 20100110